368 related articles for article (PubMed ID: 15651754)
1. Virological effects of ISIS 14803, an antisense oligonucleotide inhibitor of hepatitis C virus (HCV) internal ribosome entry site (IRES), on HCV IRES in chronic hepatitis C patients and examination of the potential role of primary and secondary HCV resistance in the outcome of treatment.
Soler M; McHutchison JG; Kwoh TJ; Dorr FA; Pawlotsky JM
Antivir Ther; 2004 Dec; 9(6):953-68. PubMed ID: 15651754
[TBL] [Abstract][Full Text] [Related]
2. A phase I trial of an antisense inhibitor of hepatitis C virus (ISIS 14803), administered to chronic hepatitis C patients.
McHutchison JG; Patel K; Pockros P; Nyberg L; Pianko S; Yu RZ; Dorr FA; Kwoh TJ
J Hepatol; 2006 Jan; 44(1):88-96. PubMed ID: 16274834
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis C IRES: translating translation into a therapeutic target.
Jubin R
Curr Opin Mol Ther; 2001 Jun; 3(3):278-87. PubMed ID: 11497352
[TBL] [Abstract][Full Text] [Related]
4. Correlation between translation efficiency and outcome of combination therapy in chronic hepatitis C genotype 3.
Yasmeen A; Hamid S; Granath FN; Lindström H; Elliott RM; Siddiqui AA; Persson MA
J Viral Hepat; 2006 Feb; 13(2):87-95. PubMed ID: 16436126
[TBL] [Abstract][Full Text] [Related]
5. Nucleotide sequence variations in the internal ribosome entry site of hepatitis C virus-1b: no association with efficacy of interferon therapy or serum HCV-RNA levels.
Yamamoto C; Enomoto N; Kurosaki M; Yu SH; Tazawa J; Izumi N; Marumo F; Sato C
Hepatology; 1997 Dec; 26(6):1616-20. PubMed ID: 9398006
[TBL] [Abstract][Full Text] [Related]
6. Short peptide nucleic acids (PNA) inhibit hepatitis C virus internal ribosome entry site (IRES) dependent translation in vitro.
Alotte C; Martin A; Caldarelli SA; Di Giorgio A; Condom R; Zoulim F; Durantel D; Hantz O
Antiviral Res; 2008 Dec; 80(3):280-7. PubMed ID: 18625270
[TBL] [Abstract][Full Text] [Related]
7. Human ribosomal protein L18a interacts with hepatitis C virus internal ribosome entry site.
Dhar D; Mapa K; Pudi R; Srinivasan P; Bodhinathan K; Das S
Arch Virol; 2006 Mar; 151(3):509-24. PubMed ID: 16195786
[TBL] [Abstract][Full Text] [Related]
8. Association with 5'-untranslated region and response to interferon in chronic hepatitis C.
Katano Y; Hayashi K; Ishigami M; Itoh A; Hirooka Y; Nakano I; Goto H
Hepatogastroenterology; 2007; 54(75):854-7. PubMed ID: 17591078
[TBL] [Abstract][Full Text] [Related]
9. Roles of the polypyrimidine tract and 3' noncoding region of hepatitis C virus RNA in the internal ribosome entry site-mediated translation.
Wang H; Shen XT; Ye R; Lan SY; Xiang L; Yuan ZH
Arch Virol; 2005 Jun; 150(6):1085-99. PubMed ID: 15747050
[TBL] [Abstract][Full Text] [Related]
10. Involvement of proteasome alpha-subunit PSMA7 in hepatitis C virus internal ribosome entry site-mediated translation.
Krüger M; Beger C; Welch PJ; Barber JR; Manns MP; Wong-Staal F
Mol Cell Biol; 2001 Dec; 21(24):8357-64. PubMed ID: 11713272
[TBL] [Abstract][Full Text] [Related]
11. Antiviral effect of ribonuclease conjugated oligodeoxynucleotides targeting the IRES RNA of the hepatitis C virus.
Gamble C; Trotard M; Le Seyec J; Abreu-Guerniou V; Gernigon N; Berrée F; Carboni B; Felden B; Gillet R
Bioorg Med Chem Lett; 2009 Jul; 19(13):3581-5. PubMed ID: 19450979
[TBL] [Abstract][Full Text] [Related]
12. A conserved RNA structure within the HCV IRES eIF3-binding site.
Collier AJ; Gallego J; Klinck R; Cole PT; Harris SJ; Harrison GP; Aboul-Ela F; Varani G; Walker S
Nat Struct Biol; 2002 May; 9(5):375-80. PubMed ID: 11927954
[TBL] [Abstract][Full Text] [Related]
13. Down-regulation of the internal ribosome entry site (IRES)-mediated translation of the hepatitis C virus: critical role of binding of the stem-loop IIId domain of IRES and the viral core protein.
Shimoike T; Koyama C; Murakami K; Suzuki R; Matsuura Y; Miyamura T; Suzuki T
Virology; 2006 Feb; 345(2):434-45. PubMed ID: 16297950
[TBL] [Abstract][Full Text] [Related]
14. A peptide derived from RNA recognition motif 2 of human la protein binds to hepatitis C virus internal ribosome entry site, prevents ribosomal assembly, and inhibits internal initiation of translation.
Pudi R; Ramamurthy SS; Das S
J Virol; 2005 Aug; 79(15):9842-53. PubMed ID: 16014945
[TBL] [Abstract][Full Text] [Related]
15. Quasispecies heterogeneity and constraints on the evolution of the 5' noncoding region of hepatitis C virus (HCV): relationship with HCV resistance to interferon-alpha therapy.
Soler M; Pellerin M; Malnou CE; Dhumeaux D; Kean KM; Pawlotsky JM
Virology; 2002 Jun; 298(1):160-73. PubMed ID: 12093183
[TBL] [Abstract][Full Text] [Related]
16. Evolution of HVR-1 quasispecies after 1-year treatment in HIV/HCV-coinfected patients according to the pattern of response to highly active antiretroviral therapy.
Solmone M; Girardi E; Lalle E; Abbate I; D'Arminio Monforte A; Cozzi-Lepri A; Alessandrini A; Piscopo R; Ebo F; Cosco L; Antonucci G; Ippolito G; Capobianchi MR; ;
Antivir Ther; 2006; 11(1):87-94. PubMed ID: 16518964
[TBL] [Abstract][Full Text] [Related]
17. A chimeric GB virus B with 5' nontranslated RNA sequence from hepatitis C virus causes hepatitis in tamarins.
Rijnbrand R; Yang Y; Beales L; Bodola F; Goettge K; Cohen L; Lanford RE; Lemon SM; Martin A
Hepatology; 2005 May; 41(5):986-94. PubMed ID: 15793797
[TBL] [Abstract][Full Text] [Related]
18. Clinical and therapeutic implications of hepatitis C virus compartmentalization.
Di Liberto G; Roque-Afonso AM; Kara R; Ducoulombier D; Fallot G; Samuel D; Feray C
Gastroenterology; 2006 Jul; 131(1):76-84. PubMed ID: 16831592
[TBL] [Abstract][Full Text] [Related]
19. Interferons alpha, beta, gamma each inhibit hepatitis C virus replication at the level of internal ribosome entry site-mediated translation.
Dash S; Prabhu R; Hazari S; Bastian F; Garry R; Zou W; Haque S; Joshi V; Regenstein FG; Thung SN
Liver Int; 2005 Jun; 25(3):580-94. PubMed ID: 15910496
[TBL] [Abstract][Full Text] [Related]
20. Interfering with hepatitis C virus IRES activity using RNA molecules identified by a novel in vitro selection method.
Romero-López C; Barroso-delJesus A; Puerta-Fernández E; Berzal-Herranz A
Biol Chem; 2005 Feb; 386(2):183-90. PubMed ID: 15843163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
